Federal contract award
W81K0026FA048
ONCOTYPE DX BREAST CANCER SCREENING AT WBAMC. FIFTEEN (15) TESTS PER PERIOD OF PERFORMANCE, WITH ONE (1) BASE YEAR AND FOUR (4) OPTION YEARS, FOR A TOTAL OF SEVENTY-FIVE (75) TESTS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 621511 — Medical Laboratories |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | V797D70053 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $51.8K |
| Current contract value | $51.8K |
| Potential contract value / ceiling | $259.0K |
| Start date | Feb 1, 2026 |
| Current end date | Jan 31, 2027 |
| Potential end date | Jan 31, 2031 |
| Latest award activity | Feb 8, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 8, 2026 | P00001 | $51.8K | ONCOTYPE DX BREAST CANCER SCREENING AT WBAMC |
| Jan 29, 2026 | 0 | $0 | ONCOTYPE DX BREAST CANCER SCREENING AT WBAMC. FIFTEEN (15) TESTS PER PERIOD OF PERFORMANCE, WITH ONE (1) BASE YEAR AND FOUR (4) OPTION YEARS, FOR A TOTAL OF SEVENTY-FIVE (75) TESTS. |
Estimated positioning window
Jan 31, 2030 – Jul 31, 2030
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2031-01-31 (1559 days from calculation)
- +5 points
- 79 historical awards in this buyer and category group
- +15 points
- 2 recorded award transactions
- +5 points
- Latest award action: 2026-02-08
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.